Literature DB >> 14074119

INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN.

E G ERDÖS, J R WOHLER.   

Abstract

Entities:  

Keywords:  ANTIMETABOLITES; BRADYKININ; CARBOXYPEPTIDASES; DIMERCAPROL; EDTA; EXPERIMENTAL LAB STUDY; GLUTATHIONE; GUINEA PIGS; MERCAPTOETHYLAMINES; PENICILLAMINE; PEPTIDES; PHARMACOLOGY; QUINOLINES; SULFHYDRYL COMPOUNDS

Mesh：

Substances：

Year:  1963        PMID： 14074119     DOI： 10.1016/0006-2952(63)90094-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

1.  A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.

Authors:  S H FERREIRA
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  Amplification of the bradykinin response in rat uterus by pCMB-Dextran T 10.

Authors:  K Mann; F Bachhuber; H Kather; B Simon
Journal:  Agents Actions       Date:  1975-08

3.  History of the development of inhibitors of angiotensin I conversion.

Authors:  S H Ferreira
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Paradoxical inhibition of the effects of bradykinin by some sulfhydryl reagents.

Authors:  B B Vargaftig
Journal:  Experientia       Date:  1972-01-15

Review 5.  Bradykinin, kallidin, and their synthetic analogues.

Authors:  E Schröder; R Hempel
Journal:  Experientia       Date:  1964-10-15

6.  Inhibitory effects of thiol compounds on kallikrein and on experimental burns in guinea-pigs.

Authors:  G E Davies; J S Lowe
Journal:  Br J Pharmacol Chemother       Date:  1966-05

Review 7.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

8.  Liberation of a bradykinin-like substance in the circulating blood of dogs by trypsin, chymotrypsin and nagarse.

Authors:  S H Ferreira; M Rocha E Silva
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

9.  What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?

Authors:  Lucas A D Nicolau; Pedro J C Magalhães; Mariana L Vale
Journal:  Med Hypotheses       Date:  2020-05-30       Impact factor: 1.538
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.